<DOC>
	<DOCNO>NCT01228292</DOCNO>
	<brief_summary>The purpose study compare feasibility , safety efficacy hemodialysis unfractionated heparin compare hemodialysis Citrasate Critically Ill Patients .</brief_summary>
	<brief_title>Comparison Slow Efficiency Daily Dialysis ( SLEDD ) With Unfractionated Heparin Versus Citrasate Critically Ill Patients .</brief_title>
	<detailed_description>Objective : To compare feasibility , safety efficacy Sustained Low Efficiency Daily Hemodialysis ( SLEDD ) use regional anticoagulation Citrasate® compare systemic anticoagulation unfractionated heparin critically ill patient . Design : Prospective , randomize , single-center clinical trial Setting : mixed medical-surgical 45 bed ICU tertiary university hospital Patients : 250 patient Acute Kidney Injury ( AKI ) stage III need renal replacement therapy Interventions : Patients randomize receive SLEDD use standard dialysate systemic anticoagulation UF versus SLEDD use Citrasate®-dialysate additional UF . Measurements main result : Primary end point : - The incidence premature interruption dialysis procedure attribute hemofilter clotting . Secondary end point : - The incidence bleed episode define WHO-criteria - The transfusion requirement - The incidence technique failure - The incidence metabolic derangement ( metabolic alkalosis , metabolic acidosis , hypocalcemia , hypercalcemia , hypernatremia , hyponatremia ) - The incidence citrate intoxication - The dialysis efficiency express Kt/V URR Tertiary end point : - All cause mortality day 28 day 90 inclusion</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Need hemodialysis ICU least one treatment No prior hemodialysis treatment ICU except continuous renal replacement therapy Need systemic anticoagulation unfractionated fractionated heparin , oral anticoagulant intravenous antiaggregants reason Need continue thrombolysis therapy within 6 hour inclusion Need continue treatment activate protein C ( drotrecogin alfa ) within 12 hour inclusion Need continue treatment intravenous antiaggregants ( abciximab , eptifabide ) within 12 hour inclusion Liver failure ( acute acuteonchronic ) Confirmed suspect Heparin Induced Thrombocytopenia ( HIT ) Heparin allergy Severe uncorrected hypocalcemia ( ionized calcium &lt; 0,8 mmol/l ) Refusal inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Anticoagulation</keyword>
	<keyword>Intensive Care Medicine</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Critical Ill Patients</keyword>
</DOC>